Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies.

Peng S, Lü B, Ruan W, Zhu Y, Sheng H, Lai M.

Breast Cancer Res Treat. 2011 Jun;127(2):309-24. doi: 10.1007/s10549-011-1459-5. Review.

PMID:
21445572
2.

A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese population.

Sueta A, Ito H, Kawase T, Hirose K, Hosono S, Yatabe Y, Tajima K, Tanaka H, Iwata H, Iwase H, Matsuo K.

Breast Cancer Res Treat. 2012 Apr;132(2):711-21. doi: 10.1007/s10549-011-1904-5.

PMID:
22160591
3.

Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.

Campa D, Kaaks R, Le Marchand L, Haiman CA, Travis RC, Berg CD, Buring JE, Chanock SJ, Diver WR, Dostal L, Fournier A, Hankinson SE, Henderson BE, Hoover RN, Isaacs C, Johansson M, Kolonel LN, Kraft P, Lee IM, McCarty CA, Overvad K, Panico S, Peeters PH, Riboli E, Sanchez MJ, Schumacher FR, Skeie G, Stram DO, Thun MJ, Trichopoulos D, Zhang S, Ziegler RG, Hunter DJ, Lindström S, Canzian F.

J Natl Cancer Inst. 2011 Aug 17;103(16):1252-63. doi: 10.1093/jnci/djr265.

4.

Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype.

Han W, Woo JH, Yu JH, Lee MJ, Moon HG, Kang D, Noh DY.

Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):793-8. doi: 10.1158/1055-9965.EPI-10-1282.

5.

Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.

Shan J, Mahfoudh W, Dsouza SP, Hassen E, Bouaouina N, Abdelhak S, Benhadjayed A, Memmi H, Mathew RA, Aigha II, Gabbouj S, Remadi Y, Chouchane L.

Breast Cancer Res Treat. 2012 Oct;135(3):715-24. doi: 10.1007/s10549-012-2202-6.

6.

Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population.

Chan M, Ji SM, Liaw CS, Yap YS, Law HY, Yoon CS, Wong CY, Yong WS, Wong NS, Ng R, Ong KW, Madhukumar P, Oey CL, Tan PH, Li HH, Ang P, Ho GH, Lee AS.

Breast Cancer Res Treat. 2012 Nov;136(1):209-20. doi: 10.1007/s10549-012-2234-y.

PMID:
22965832
7.

Risk of genome-wide association study newly identified genetic variants for breast cancer in Chinese women of Heilongjiang Province.

Jiang Y, Han J, Liu J, Zhang G, Wang L, Liu F, Zhang X, Zhao Y, Pang D.

Breast Cancer Res Treat. 2011 Jul;128(1):251-7. doi: 10.1007/s10549-010-1327-8.

PMID:
21197568
8.

A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study.

Kim HC, Lee JY, Sung H, Choi JY, Park SK, Lee KM, Kim YJ, Go MJ, Li L, Cho YS, Park M, Kim DJ, Oh JH, Kim JW, Jeon JP, Jeon SY, Min H, Kim HM, Park J, Yoo KY, Noh DY, Ahn SH, Lee MH, Kim SW, Lee JW, Park BW, Park WY, Kim EH, Kim MK, Han W, Lee SA, Matsuo K, Shen CY, Wu PE, Hsiung CN, Lee JY, Kim HL, Han BG, Kang D.

Breast Cancer Res. 2012 Mar 27;14(2):R56.

9.

Association between mitogen-activated protein kinase kinase kinase 1 rs889312 polymorphism and breast cancer risk: evidence from 59,977 subjects.

Lu PH, Yang J, Li C, Wei MX, Shen W, Shi LP, Jiang ZY, Zhou N, Tao GQ.

Breast Cancer Res Treat. 2011 Apr;126(3):663-70. doi: 10.1007/s10549-010-1151-1.

PMID:
20809358
10.

Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population.

Jara L, Gonzalez-Hormazabal P, Cerceño K, Di Capua GA, Reyes JM, Blanco R, Bravo T, Peralta O, Gomez F, Waugh E, Margarit S, Ibañez G, Romero C, Pakomio J, Roizen G.

Breast Cancer Res Treat. 2013 Jan;137(2):559-69. doi: 10.1007/s10549-012-2359-z.

PMID:
23225170
11.

Evaluation of breast cancer susceptibility loci in Chinese women.

Long J, Shu XO, Cai Q, Gao YT, Zheng Y, Li G, Li C, Gu K, Wen W, Xiang YB, Lu W, Zheng W.

Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2357-65. doi: 10.1158/1055-9965.EPI-10-0054.

12.

An empirical comparison of meta-analyses of published gene-disease associations versus consortium analyses.

Janssens AC, González-Zuloeta Ladd AM, López-Léon S, Ioannidis JP, Oostra BA, Khoury MJ, van Duijn CM.

Genet Med. 2009 Mar;11(3):153-62. doi: 10.1097/GIM.0b013e3181929237.

PMID:
19367188
13.

Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study.

Milne RL, Gaudet MM, Spurdle AB, Fasching PA, Couch FJ, Benítez J, Arias Pérez JI, Zamora MP, Malats N, Dos Santos Silva I, Gibson LJ, Fletcher O, Johnson N, Anton-Culver H, Ziogas A, Figueroa J, Brinton L, Sherman ME, Lissowska J, Hopper JL, Dite GS, Apicella C, Southey MC, Sigurdson AJ, Linet MS, Schonfeld SJ, Freedman DM, Mannermaa A, Kosma VM, Kataja V, Auvinen P, Andrulis IL, Glendon G, Knight JA, Weerasooriya N, Cox A, Reed MW, Cross SS, Dunning AM, Ahmed S, Shah M, Brauch H, Ko YD, Brüning T; GENICA Network., Lambrechts D, Reumers J, Smeets A, Wang-Gohrke S, Hall P, Czene K, Liu J, Irwanto AK, Chenevix-Trench G, Holland H; kConFab.; AOCS., Giles GG, Baglietto L, Severi G, Bojensen SE, Nordestgaard BG, Flyger H, John EM, West DW, Whittemore AS, Vachon C, Olson JE, Fredericksen Z, Kosel M, Hein R, Vrieling A, Flesch-Janys D, Heinz J, Beckmann MW, Heusinger K, Ekici AB, Haeberle L, Humphreys MK, Morrison J, Easton DF, Pharoah PD, García-Closas M, Goode EL, Chang-Claude J.

Breast Cancer Res. 2010;12(6):R110. doi: 10.1186/bcr2797.

14.

Quantitative assessment of the effect of FGFR2 gene polymorphism on the risk of breast cancer.

Jia C, Cai Y, Ma Y, Fu D.

Breast Cancer Res Treat. 2010 Nov;124(2):521-8. doi: 10.1007/s10549-010-0872-5. Erratum in: Breast Cancer Res Treat. 2010 Nov;124(2):529. Jia, Chenyou [corrected to Jia, Chengyou].

PMID:
20364400
15.

A systematic review of the relationship between polymorphic sites in the estrogen receptor-beta (ESR2) gene and breast cancer risk.

Yu KD, Rao NY, Chen AX, Fan L, Yang C, Shao ZM.

Breast Cancer Res Treat. 2011 Feb;126(1):37-45. doi: 10.1007/s10549-010-0891-2.

PMID:
20390341
16.

Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes.

Riaz M, Berns EM, Sieuwerts AM, Ruigrok-Ritstier K, de Weerd V, Groenewoud A, Uitterlinden AG, Look MP, Klijn JG, Sleijfer S, Foekens JA, Martens JW.

Breast Cancer Res Treat. 2012 Jun;133(3):843-51. doi: 10.1007/s10549-011-1663-3.

PMID:
21748294
17.

GSTT1 and GSTP1 polymorphisms and breast cancer risk: a meta-analysis.

Sergentanis TN, Economopoulos KP.

Breast Cancer Res Treat. 2010 May;121(1):195-202. doi: 10.1007/s10549-009-0520-0.

PMID:
19760040
18.

Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis.

Sergentanis TN, Economopoulos KP.

Breast Cancer Res Treat. 2010 Feb;120(1):229-34. doi: 10.1007/s10549-009-0471-5.

PMID:
19629679
19.

The role of genetic breast cancer susceptibility variants as prognostic factors.

Fasching PA, Pharoah PD, Cox A, Nevanlinna H, Bojesen SE, Karn T, Broeks A, van Leeuwen FE, van't Veer LJ, Udo R, Dunning AM, Greco D, Aittomäki K, Blomqvist C, Shah M, Nordestgaard BG, Flyger H, Hopper JL, Southey MC, Apicella C, Garcia-Closas M, Sherman M, Lissowska J, Seynaeve C, Huijts PE, Tollenaar RA, Ziogas A, Ekici AB, Rauh C, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Andrulis IL, Ozcelik H, Mulligan AM, Glendon G, Hall P, Czene K, Liu J, Chang-Claude J, Wang-Gohrke S, Eilber U, Nickels S, Dörk T, Schiekel M, Bremer M, Park-Simon TW, Giles GG, Severi G, Baglietto L, Hooning MJ, Martens JW, Jager A, Kriege M, Lindblom A, Margolin S, Couch FJ, Stevens KN, Olson JE, Kosel M, Cross SS, Balasubramanian SP, Reed MW, Miron A, John EM, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Kauppila S, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Chenevix-Trench G; kConFab Investigators., Lambrechts D, Dieudonne AS, Hatse S, van Limbergen E, Benitez J, Milne RL, Zamora MP, Pérez JI, Bonanni B, Peissel B, Loris B, Peterlongo P, Rajaraman P, Schonfeld SJ, Anton-Culver H, Devilee P, Beckmann MW, Slamon DJ, Phillips KA, Figueroa JD, Humphreys MK, Easton DF, Schmidt MK.

Hum Mol Genet. 2012 Sep 1;21(17):3926-39. doi: 10.1093/hmg/dds159.

20.

A systematic review of genetic polymorphisms and breast cancer risk.

Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA, Easton DF.

Cancer Epidemiol Biomarkers Prev. 1999 Oct;8(10):843-54. Review.

Supplemental Content

Support Center